Article
Dundee, Scotland - A routine cell culture of a patient with epidermolysis bullosa simplex (EBS) has led to the inadvertent discovery of a revertant mutation that deactivates the original pathogenic mutation, according to Irwin McLean, Ph.D.
Daily Derm Times: February 14, 2025
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Nektar's Jonathan Zalevsky, PhD, Dives Into Rezpegaldesleukin Fast Track Designation for Atopic Dermatitis
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
New Data on Bimekizumab’s Long-term HS Efficacy
How Well Revolution Combines In-Person Care with Telehealth